311 related articles for article (PubMed ID: 17548652)
1. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23-->IL-17 axis.
Sheibanie AF; Yen JH; Khayrullina T; Emig F; Zhang M; Tuma R; Ganea D
J Immunol; 2007 Jun; 178(12):8138-47. PubMed ID: 17548652
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
[TBL] [Abstract][Full Text] [Related]
3. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.
Khayrullina T; Yen JH; Jing H; Ganea D
J Immunol; 2008 Jul; 181(1):721-35. PubMed ID: 18566439
[TBL] [Abstract][Full Text] [Related]
4. BLT1 in dendritic cells promotes Th1/Th17 differentiation and its deficiency ameliorates TNBS-induced colitis.
Zhou J; Lai W; Yang W; Pan J; Shen H; Cai Y; Yang C; Ma N; Zhang Y; Zhang R; Xie X; Dong Z; Gao Y; Du C
Cell Mol Immunol; 2018 Dec; 15(12):1047-1056. PubMed ID: 29670278
[TBL] [Abstract][Full Text] [Related]
5. Total Glycosides of Peony Protects Against Inflammatory Bowel Disease by Regulating IL-23/IL-17 Axis and Th17/Treg Balance.
Li Q; Shan Q; Sang X; Zhu R; Chen X; Cao G
Am J Chin Med; 2019; 47(1):177-201. PubMed ID: 30612460
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells.
Sheibanie AF; Tadmori I; Jing H; Vassiliou E; Ganea D
FASEB J; 2004 Aug; 18(11):1318-20. PubMed ID: 15180965
[TBL] [Abstract][Full Text] [Related]
7. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
Shen W; Durum SK
Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
[TBL] [Abstract][Full Text] [Related]
8. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
9. A single administration of human adipose tissue-derived mesenchymal stromal cells (MSC) induces durable and sustained long-term regulation of inflammatory response in experimental colitis.
Alves VBF; de Sousa BC; Fonseca MTC; Ogata H; Caliári-Oliveira C; Yaochite JNU; Rodrigues Júnior V; Chica JEL; da Silva JS; Malmegrim KCR; Pernomian L; Cardoso CR
Clin Exp Immunol; 2019 May; 196(2):139-154. PubMed ID: 30663040
[TBL] [Abstract][Full Text] [Related]
10. Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
Krajina T; Leithäuser F; Möller P; Trobonjaca Z; Reimann J
Eur J Immunol; 2003 Apr; 33(4):1073-83. PubMed ID: 12672074
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
[TBL] [Abstract][Full Text] [Related]
12. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production.
Feng T; Qin H; Wang L; Benveniste EN; Elson CO; Cong Y
J Immunol; 2011 Jun; 186(11):6313-8. PubMed ID: 21531892
[TBL] [Abstract][Full Text] [Related]
13. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus ameliorates inflammatory responses by switching the regulatory T/T helper type 17 profile in murine colitis.
Yin H; Li X; Zhang B; Liu T; Yuan B; Ni Q; Hu S; Gu H
Immunology; 2013 Aug; 139(4):494-502. PubMed ID: 23480027
[TBL] [Abstract][Full Text] [Related]
17. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
18. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.
Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155
[TBL] [Abstract][Full Text] [Related]
19. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.
Kabashima K; Saji T; Murata T; Nagamachi M; Matsuoka T; Segi E; Tsuboi K; Sugimoto Y; Kobayashi T; Miyachi Y; Ichikawa A; Narumiya S
J Clin Invest; 2002 Apr; 109(7):883-93. PubMed ID: 11927615
[TBL] [Abstract][Full Text] [Related]
20. Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa.
Kim DJ; Kim KS; Song MY; Seo SH; Kim SJ; Yang BG; Jang MH; Sung YC
Clin Immunol; 2012 Sep; 144(3):190-9. PubMed ID: 22836084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
